Healthcare Industry News: Ampion
News Release - November 27, 2006
Galil Medical, an Elron Group Company, Signs Definitive Agreements to Sell Interest in Oncura and to Acquire Oncura's Urology Related Cryotherapy BusinessTEL AVIV, Israel--(HSMN NewsFeed)--Elron Electronic Industries Ltd. (NASDAQ: ELRN ; TASE: ELRN), announced today that further to its announcement on November 22, 2006, Galil Medical Ltd., an Elron group company, has signed definitive agreements for the sale of its 25% interest in Oncura, Inc. to Oncura's 75% shareholder, GE ChAmpion Services and the acquisition of Oncura's urology related cryotherapy business from Oncura. The completion of the transaction is subject to certain closing conditions and there is no assurance that the transaction will be completed.
Elron Electronic Industries Ltd. (TASE & NASDAQ: ELRN), a member of the IDB Holding group, is a leading Israel-based technology holding company directly involved in the long-term performance of its group companies. Elron identifies potential technologies, creates strategic partnerships, secures financing, and recruits highly qualified management teams. Elron's group companies currently comprise a diverse range of publicly-traded and privately held companies primarily in the fields of medical devices, information & communications technology, clean technology and semiconductors. For further information, please visit www.elron.com
Any statements in this press release that may be considered forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially. Actual results may differ from such forward-looking statements due to the risk factors discussed in periodic reports filed by the Company with the Securities and Exchange Commission, which the Company urges investors to consider.
Source: Elron Electronic Industries
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.